Compugen Ltd.

Compugen Ltd.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
34.32 M
Public Float
-
Compugen Ltd.
Stock Exchange NASDAQ Stock Market
EPS
$0.55
Market Cap
$227.03 M
Shares Outstanding
59.9 M
Public Float
54.76 M

Profile

Address
Azrieli Center
Holon TA 58858
Israel
Employees -
Website http://www.cgen.com
Updated 07/08/2019
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.

Financials

View All

Paul Jai Sekhri
Chairman
Anat Cohen-Dayag
President, Chief Executive Officer & Director